Company Overview: MKS Instruments, Inc. (NASDAQ: MKSI) offers instruments, systems, subsystems, and process control solutions for sophisticated manufacturing processes that measure, monitor, deliver, analyse, power, and control critical parameters. Its operating segments are 1) Vacuum & Analysis (V&A), which provides various products in the gas and vapor delivery, gas composition analysis, electronic control technology, reactive gas generation, power generation, and vacuum technology fields, 2) Light & Motion (L&M), comprising a portfolio of lasers, photonics, optics, temperature sensing, precision motion control and vibration control products, and 3) Equipment & Solutions (E&S), involved in the marketing of a range of products including a laser-based system for manufacturing of Printed Circuit Board (PCB).

MKSI Details


Key Takeaways from Q3FY21 (ended September 30, 2021)

Revenues & Gross Profit Key Highlights; Analysis by Kalkine Group
Recent Developments:
Segment Wise Results Q3FY21
Balance Sheet & Liquidity Position
Key Metrics: In Q3FY21, MKSI's operating and net margins were 23.6% and 17.8%, higher than 19.7% and 15.5%, respectively, reported in Q3FY20. ROE stood at 5.0%, 80 bps higher than the Q3FY20 return. Debt/Equity was 0.30x as of September 30, 2021, lower than 0.37x on September 30, 2020.

Profitability and Leverage Profile; Analysis by Kalkine Group
Top 10 Shareholders: The top 10 shareholders together form around 48.96% of the total shareholding, while the top 4 constitute the maximum holding. The Vanguard Group, Inc. and Wellington Management Co., LLP hold the maximum stake in the company at 10.23% and 8.79%, respectively, as also highlighted in the chart below:

Top 10 Shareholders; Analysis by Kalkine Group
Risk Analysis
Outlook
Valuation Methodology: EV/Sales Multiple Based Relative Valuation (Illustrative)

Source: Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation: Over the last six months, MKSI's share price has corrected 13.30%. The stock is currently trading close to the mid-point of its 52-week range of USD 111.13 to USD 199.44. We have valued the stock using the EV/Sales multiple-based illustrative relative valuation method and arrived at a target price with an upside of low twenties (in percentage terms). We believe that the company can trade at a slight discount compared to its peer's average, considering its customer and industry concentration, currency risks and dependence on a limited number of suppliers. We have taken peers like CyberOptics Corporation (NASDAQ: CYBE) and AXT Inc. (NASDAQ: AXTI). Considering the strong top and bottom-line performance, improved profitability margins, recent acquisitions, decent outlook, and current valuation, we give a "Buy" recommendation on the stock at the current price of USD 153.0, down 0.59% as of November 03, 2021, 10.22 AM ET.


MKSI Technical Chart, Data Source: REFINITIV
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decision should be made depending on the investors' appetite for upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the valuation has been achieved and subject to the factors discussed above.
Technical Indicators Defined
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and the uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer
Kalkine New Zealand Limited is authorised to provide general advice only. The information on this website does not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions.
Past performance is not a reliable indicator of future performance.